The problem of stem cell fragility, a major hurdle that has long-hindered the progress of stem cell research, has been solved. Scientists working with the Scripps Research Institute say they have identified the mechanisms responsible for stem cell fragility.
During the culture process, stem cells frequently die unless very meticulous, labor-intensive steps are taken to keep them alive. By introducing two compounds called Thiazovivin and Pyrintegrin, the cells are protected, increasing their survival rate significantly.
Developments in stem cell research, though a subject of debate, offer hope for revolutionary therapeutic purposes, including treatment of injuries, diabetes, Parkinson’s disease, and aging. The regenerative properties of pluripotent stem cells could facilitate tissue repair in a variety of applications – even cosmetic treatments.